Drug Patents owned by Otter Pharms

1. List of Otrexup drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11446441 OTTER PHARMS Prefilled syringe injector
Jan, 2026

(2 years from now)

US9629959 OTTER PHARMS Prefilled syringe jet injector
Jan, 2026

(2 years from now)

US9533102 OTTER PHARMS Prefilled syringe jet injector
Jan, 2026

(2 years from now)

US8562564 OTTER PHARMS Prefilled syringe jet injector
Jan, 2026

(2 years from now)

US8021335 OTTER PHARMS Prefilled syringe jet injector
Oct, 2026

(3 years from now)

US9867949 OTTER PHARMS Injector safety device
Mar, 2029

(6 years from now)

US10709844 OTTER PHARMS Injector safety device
Mar, 2029

(6 years from now)

US11497753 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(7 years from now)

US8579865 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(7 years from now)

US8945063 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(7 years from now)

US9421333 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(7 years from now)

US8480631 OTTER PHARMS Hazardous agent injection system
Mar, 2030

(7 years from now)

US8814834 OTTER PHARMS Injector safety device
May, 2031

(8 years from now)

Drugs and Companies using METHOTREXATE ingredient

Market Authorisation Date: 11 October, 2013

Treatment: Subcutaneous injection of methotrexate

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

2. List of Sympazan drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11541002 OTTER PHARMS NA
Sep, 2039

(16 years from now)

Drugs and Companies using CLOBAZAM ingredient

Market Authorisation Date: 01 November, 2018

Treatment: Method of treating seizures

Dosage: FILM;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic